Epigenetics and liquid biopsy for meningioma patients
Part of Brain & nervous system, Cancer clinical trials.
This study looks at genetic changes in meningioma tumors and body fluids to find ways to personalize treatment. It may help doctors better predict how the tumor will behave and choose the best therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed for the first time with a single meningioma on the brain's convexity (the outer surface).
- You must have had a surgery that removed the entire tumor (Simpson grade 1, 2, or 3).
- If you're in the retrospective part, your surgery must have taken place between 2007 and 2016, and a sample of your tumor must be available.
- You cannot have any known genetic syndromes or diffuse meningeal meningiomatosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at tiny particles called extracellular vesicles in the blood of people with meningioma, a type of brain tumor. The goal is to learn more about these particles and how they relate to the tumor, which may help in understanding the disease better.
This study looks for tumor cells in your blood or spinal fluid to see if they can help track aggressive meningiomas that have come back. It may help doctors understand your cancer better and guide future treatments.
This study looks at how your tumor's genes, personal health habits, and other factors affect your long-term health after a meningioma diagnosis. You'll be asked to complete surveys about your health and experiences—no new treatments or procedures are involved.
This study collects samples of spinal fluid and blood from people with solid tumours that have spread to the brain or spine, or who have primary brain tumours. The goal is see if these samples can help doctors detect and monitor these cancers more easily.
This trial studies whether changes in RNA (the instructions inside cells) can help doctors better diagnose and treat gliomas, a type of brain tumor. If you are scheduled for surgery to remove a suspected glioma and have not had prior treatment, you may be able to join.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.